Ayano Nakayama1, David J Tunnicliffe2, Vivek Thakkar2, Davinder Singh-Grewal2, Sean O'Neill2, Jonathan C Craig2, Allison Tong2. 1. From the Centre for Kidney Research, and Department of Rheumatology, The Children's Hospital at Westmead; Sydney School of Public Health, and Discipline of Paediatrics and Child Health, University of Sydney; School of Maternal and Child Health, University of New South Wales; Department of Rheumatology, Liverpool Hospital, Sydney; Department of Rheumatology, Canberra Hospital, Canberra; School of Medicine, University of Western Sydney, Campbelltown; South West Sydney Clinical School, University of New South Wales, Liverpool, Australia.A. Nakayama, MBBS, Centre for Kidney Research, The Children's Hospital at Westmead, and Department of Rheumatology, Canberra Hospital; D.J. Tunnicliffe, MIPH, Centre for Kidney Research, The Children's Hospital at Westmead, and Sydney School of Public Health, University of Sydney; V. Thakkar, MD, Department of Rheumatology, Liverpool Hospital, and School of Medicine, University of Western Sydney, and South West Sydney Clinical School, University of New South Wales; D. Singh-Grewal, PhD, Associate Professor, Department of Rheumatology, The Children's Hospital at Westmead, and Discipline of Paediatrics and Child Health, University of Sydney, and School of Maternal and Child Health, University of New South Wales, and Department of Rheumatology, Liverpool Hospital; S. O'Neill, PhD, Professor, Department of Rheumatology, Liverpool Hospital, and South West Sydney Clinical School, University of New South Wales; J.C. Craig, PhD, Associate Professor, Centre for Kidney Research, The Children's Hospital at Westmead, and Sydney School of Public Health, University of Sydney; A. Tong, PhD, Centre for Kidney Research, The Children's Hospital at Westmead, and Sydney School of Public Health, University of Sydney. Ayano.Nakayama@act.gov.au. 2. From the Centre for Kidney Research, and Department of Rheumatology, The Children's Hospital at Westmead; Sydney School of Public Health, and Discipline of Paediatrics and Child Health, University of Sydney; School of Maternal and Child Health, University of New South Wales; Department of Rheumatology, Liverpool Hospital, Sydney; Department of Rheumatology, Canberra Hospital, Canberra; School of Medicine, University of Western Sydney, Campbelltown; South West Sydney Clinical School, University of New South Wales, Liverpool, Australia.A. Nakayama, MBBS, Centre for Kidney Research, The Children's Hospital at Westmead, and Department of Rheumatology, Canberra Hospital; D.J. Tunnicliffe, MIPH, Centre for Kidney Research, The Children's Hospital at Westmead, and Sydney School of Public Health, University of Sydney; V. Thakkar, MD, Department of Rheumatology, Liverpool Hospital, and School of Medicine, University of Western Sydney, and South West Sydney Clinical School, University of New South Wales; D. Singh-Grewal, PhD, Associate Professor, Department of Rheumatology, The Children's Hospital at Westmead, and Discipline of Paediatrics and Child Health, University of Sydney, and School of Maternal and Child Health, University of New South Wales, and Department of Rheumatology, Liverpool Hospital; S. O'Neill, PhD, Professor, Department of Rheumatology, Liverpool Hospital, and South West Sydney Clinical School, University of New South Wales; J.C. Craig, PhD, Associate Professor, Centre for Kidney Research, The Children's Hospital at Westmead, and Sydney School of Public Health, University of Sydney; A. Tong, PhD, Centre for Kidney Research, The Children's Hospital at Westmead, and Sydney School of Public Health, University of Sydney.
Abstract
OBJECTIVE: Systemic sclerosis (SSc) is a chronic, progressive autoimmune disease with major end-organ involvement. Much attention has been focused on the management of physical and clinical manifestations; however, the effect of the disease and treatment on the patient's identity, relationships, functioning, and mental well-being are less known. We aimed to describe the patients' perspectives and experiences of living with SSc. METHODS: Electronic databases were searched to October 2014. Thematic synthesis was used to analyze the findings. RESULTS: We included 26 studies involving 463 patients. Six key themes were identified: distressing appearance transformation (disturbing facial changes, stigmatizing sickness, unrecognizable self), palpable physical limitations (bodily restrictions, frustrating mind-body disconnect, pervasive fatigue, disabling pain), social impairment (breaking intimacy, struggling to fulfill family responsibilities, maintaining work, losing independence), navigating uncertainty (diagnostic ambiguity, medically fending for oneself, unpredictable course of illness), alone and misunderstood (fearful avoidance of fellow patients, invisible suffering), and gradual acceptance and relative optimism (adapting to change and accepting limitations, taking a positive spin, cautious hoping, empowering relationships, valuing medical support). CONCLUSION: SSc is a rare and unpredictable illness that undermines patients' sense of certainty and control and impairs their self-image, identity, and daily functioning. Patient-centered care that encompasses strategies to promote self-esteem, resilience, and self-efficacy may help to improve treatment satisfaction and health and quality of life outcomes for patients with SSc.
OBJECTIVE: Systemic sclerosis (SSc) is a chronic, progressive autoimmune disease with major end-organ involvement. Much attention has been focused on the management of physical and clinical manifestations; however, the effect of the disease and treatment on the patient's identity, relationships, functioning, and mental well-being are less known. We aimed to describe the patients' perspectives and experiences of living with SSc. METHODS: Electronic databases were searched to October 2014. Thematic synthesis was used to analyze the findings. RESULTS: We included 26 studies involving 463 patients. Six key themes were identified: distressing appearance transformation (disturbing facial changes, stigmatizing sickness, unrecognizable self), palpable physical limitations (bodily restrictions, frustrating mind-body disconnect, pervasive fatigue, disabling pain), social impairment (breaking intimacy, struggling to fulfill family responsibilities, maintaining work, losing independence), navigating uncertainty (diagnostic ambiguity, medically fending for oneself, unpredictable course of illness), alone and misunderstood (fearful avoidance of fellow patients, invisible suffering), and gradual acceptance and relative optimism (adapting to change and accepting limitations, taking a positive spin, cautious hoping, empowering relationships, valuing medical support). CONCLUSION: SSc is a rare and unpredictable illness that undermines patients' sense of certainty and control and impairs their self-image, identity, and daily functioning. Patient-centered care that encompasses strategies to promote self-esteem, resilience, and self-efficacy may help to improve treatment satisfaction and health and quality of life outcomes for patients with SSc.
Entities:
Keywords:
HEALTH BEHAVIOR; QUALITATIVE RESEARCH; QUALITY OF LIFE/PSYCHOLOGY; REVIEW; SOCIAL SUPPORT; SYSTEMIC SCLEROSIS
Authors: Alain Lescoat; Susan L Murphy; Yen T Chen; Nadia Vann; Francesco Del Galdo; David Cella; Maya H Buch; Dinesh Khanna Journal: Semin Arthritis Rheum Date: 2021-11-07 Impact factor: 5.431
Authors: Zachary S Wallace; Claire Cook; Lucy Finkelstein-Fox; Xiaoqing Fu; Flavia V Castelino; Hyon K Choi; Cory Perugino; John H Stone; Elyse R Park; Daniel L Hall Journal: J Rheumatol Date: 2022-04-01 Impact factor: 5.346
Authors: Juliane K Stöcker; Madelon C Vonk; Frank H J van den Hoogen; Maria W G Nijhuis-van der Sanden; Julia Spierings; J Bart Staal; Ton Satink; Cornelia H M van den Ende Journal: BMC Rheumatol Date: 2020-07-31
Authors: Susan L Murphy; Anna L Kratz; Daniel Whibley; Janet L Poole; Dinesh Khanna Journal: Arthritis Care Res (Hoboken) Date: 2021-02-05 Impact factor: 4.794
Authors: Henrik Pettersson; Helene Alexanderson; Janet L Poole; Janos Varga; Malin Regardt; Anne-Marie Russell; Yasser Salam; Kelly Jensen; Jennifer Mansour; Tracy Frech; Carol Feghali-Bostwick; Cecília Varjú; Nancy Baldwin; Matty Heenan; Kim Fligelstone; Monica Holmner; Matthew R Lammi; Mary Beth Scholand; Lee Shapiro; Elizabeth R Volkmann; Lesley Ann Saketkoo Journal: Best Pract Res Clin Rheumatol Date: 2021-07-01 Impact factor: 4.991
Authors: Julia Spierings; Cornelia H M van den Ende; Rita M Schriemer; Hein J Bernelot Moens; Egon A van der Bijl; Femke Bonte-Mineur; Marieke P D de Buck; Meeke A E de Kanter; Hanneke K A Knaapen-Hans; Jacob M van Laar; Udo D J Mulder; Judith Potjewijd; Lian A J de Pundert; Thea H M Schoonbrood; Anne A Schouffoer; Alja J Stel; Ward Vercoutere; Alexandre E Voskuyl; Jeska K de Vries-Bouwstra; Madelon C Vonk Journal: Rheumatology (Oxford) Date: 2020-06-01 Impact factor: 7.580